Exchange: NASDAQ·Updated 01:25 PM EDT
VERU logo

VERU Veru Inc

$2.48
$0.025
(1.00%)
Today
EarningsDec 17
Mkt Cap$42.63M
Vol183,099.00

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.
71

Bullish Sentiment

How do you feel about VERU?

Advertisement|Remove ads.